CheckMyRecalls

Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE…

Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride Tablets

Published
9 Apr 2025
Units affected
8160 bottles
Agency
FDA
Country
United States

The hazard

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lot#s: 17232222 and 17232237, Exp 10/31/2025
Distribution
Nationwide in the USA and PR
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.